Skip to main content

Table 1 Details of discarded diagnostic samples from patients used in the study. The numbers in parentheses indicate the number of patients in each group

From: Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virus

Sample set Quality Survival Analysis
EBOV-positive samples for RNA-seq (n = 138) Poor quality: removed from analysis (n = 26) N/A N/A
Good-quality samples (n = 112) Survived (n = 24) Transcriptomic analysis for differential gene expression and classifier generation
Fatal (n= 88)
EBOV-positive and malaria-negative (n = 37) N/A Fatal (n = 20) Flow analysis
Survived (n = 17)
Febrile and EBOV-negative (n = 10) N/A N/A
Malaria-positive and EBOV-negative (n = 5) N/A N/A
EBOV-positive sample with similar Ct values (n = 20) Good quality (n = 20) Survived (n = 10) Validation dataset for differential gene expression and classifiers
Fatal (n = 10)
Convalescent EBOV-negative (n = 16) Good quality (n = 16) Survived (n = 16) Control for EBOV-positive samples
Healthy controls (n = 6) Good quality (n = 6) Never infected (n = 6) Comparator for convalescent samples